Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Short term Debt (2024 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Short term Debt for 2 consecutive years, with $40.7 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Short term Debt changed N/A year-over-year to $40.7 million, compared with a TTM value of $40.7 million through Mar 2025, changed N/A, and an annual FY2024 reading of $40.7 million, changed N/A over the prior year.
  • Short term Debt was $40.7 million for Q1 2025 at Tandem Diabetes Care, roughly flat from $40.7 million in the prior quarter.
  • Across five years, Short term Debt topped out at $40.7 million in Q1 2025 and bottomed at $40.5 million in Q2 2024.